Halozyme Therapeutics Inc. News
Who Will Survive?: Cramer's 'Mad Money' Recap (Thursday 5/14/20)
Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.
It's Bad, But It's Not a Crash: Cramer's 'Mad Money' Recap
In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.
Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round
Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.
Roku, Sierra Wireless, Visa, Cimarex Energy: 'Mad Money' Lightning Round
Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.
Good Things Come to Those Who Buy: Cramer's 'Mad Money' Recap
Don't buy big here and don't buy all at once, but it's not too late to ride this bull to profits, says Jim Cramer.
Exxon, Chevron, Cimarex Energy: 'Mad Money' Lightning Round
Jim Cramer is bullish on Exxon, Chevron, Cimarex Energy, Skechers USA, and Halozyme Therapeutics.
Trump Doesn't Get All the Credit: Cramer's 'Mad Money' Recap
Jim Cramer says President Trump has been a great salesman, but when we look at winning stocks, it's the strong CEOs who are driving success.
What's Hot and What's Not: Cramer's 'Mad Money' Recap (Thursday 10/12/17)
In this sometimes fickle market, supply and demand are still at play.
Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers
Pharma giant aims to develop cancer drug delivery technology. Halozyme shares are up more than 16% in pre-market trading.
Sticker Shock: Ford Lifts Price Tag on 2023 F-150 Lightning Pro, Again
Those waiting to get their hands on Ford's all-electric F-150 Lightning aren’t just going to have to wait longer. They’re going to have to pay more.
More Details Emerge About Universal Studios' Disney World Killer
Universal Studios has begun construction on Epic Universe, its third theme park planned for Florida.